154 related articles for article (PubMed ID: 9236836)
1. p53 and K-ras mutational genotyping in pulmonary carcinosarcoma, spindle cell carcinoma, and pulmonary blastoma: implications for histogenesis.
Holst VA; Finkelstein S; Colby TV; Myers JL; Yousem SA
Am J Surg Pathol; 1997 Jul; 21(7):801-11. PubMed ID: 9236836
[TBL] [Abstract][Full Text] [Related]
2. Mutations in the p53 gene in pulmonary blastomas: immunohistochemical and molecular studies.
Bodner SM; Koss MN
Hum Pathol; 1996 Nov; 27(11):1117-23. PubMed ID: 8912818
[TBL] [Abstract][Full Text] [Related]
3. Aberrant nuclear/cytoplasmic localization and gene mutation of beta-catenin in classic pulmonary blastoma: beta-catenin immunostaining is useful for distinguishing between classic pulmonary blastoma and a blastomatoid variant of carcinosarcoma.
Nakatani Y; Miyagi Y; Takemura T; Oka T; Yokoi T; Takagi M; Yokoyama S; Kashima K; Hara K; Yamada T; Nozawa A; Inayama Y; Sakamoto K; Ogawa N; Kitamura H; Resl M; Cho SH; Koss MN; Mark EJ
Am J Surg Pathol; 2004 Jul; 28(7):921-7. PubMed ID: 15223963
[TBL] [Abstract][Full Text] [Related]
4. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.
Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD
Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922
[TBL] [Abstract][Full Text] [Related]
5. Molecular evidence that most but not all carcinosarcomas of the uterus are combination tumors.
Wada H; Enomoto T; Fujita M; Yoshino K; Nakashima R; Kurachi H; Haba T; Wakasa K; Shroyer KR; Tsujimoto M; Hongyo T; Nomura T; Murata Y
Cancer Res; 1997 Dec; 57(23):5379-85. PubMed ID: 9393763
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic features and genomic analysis of pulmonary blastomatoid carcinosarcoma.
Zhao J; Xiang C; Zhao R; Guo P; Zheng J; Han-Zhang H; Yu K; Zhang J; Han Y
BMC Cancer; 2020 Mar; 20(1):248. PubMed ID: 32209061
[TBL] [Abstract][Full Text] [Related]
7. The origin and molecular characterization of adenoid basal carcinoma of the uterine cervix.
Jones MW; Kounelis S; Papadaki H; Bakker A; Swalsky PA; Finkelstein SD
Int J Gynecol Pathol; 1997 Oct; 16(4):301-6. PubMed ID: 9421067
[TBL] [Abstract][Full Text] [Related]
8. Proliferative activity, p53 accumulation and neoangiogenesis in pulmonary carcinosarcomas and pulmonary blastomas.
Theegarten D; Zorn M; Philippou S
Gen Diagn Pathol; 1998 Apr; 143(5-6):265-70. PubMed ID: 9653906
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary blastoma, carcinosarcoma and spindle-cell carcinoma: an immunohistochemical study of keratin intermediate filaments.
Addis BJ; Corrin B
J Pathol; 1985 Dec; 147(4):291-301. PubMed ID: 2418184
[TBL] [Abstract][Full Text] [Related]
10. Bronchioloalveolar adenocarcinoma of lung: monoclonal origin for multifocal disease.
Holst VA; Finkelstein S; Yousem SA
Am J Surg Pathol; 1998 Nov; 22(11):1343-50. PubMed ID: 9808126
[TBL] [Abstract][Full Text] [Related]
11. Clonality and heterogeneity of pulmonary blastoma from the viewpoint of genetic alterations: a case report.
Takahashi K; Kohno T; Matsumoto S; Nakanishi Y; Arai Y; Fujiwara T; Tanaka N; Yokota J
Lung Cancer; 2007 Jul; 57(1):103-8. PubMed ID: 17350138
[TBL] [Abstract][Full Text] [Related]
12. Molecular analysis of p53 and K-ras in lung carcinomas of coal miners.
Sarkar FH; Li Y; Vallyathan V
Int J Mol Med; 2001 Oct; 8(4):453-9. PubMed ID: 11562787
[TBL] [Abstract][Full Text] [Related]
13. Pleomorphic (giant and spindle cell) carcinoma is genetically distinct from adenocarcinoma and squamous cell carcinoma by K-ras-2 and p53 analysis.
Przygodzki RM; Koss MN; Moran CA; Langer JC; Swalsky PA; Fishback N; Bakker A; Finkelstein SD
Am J Clin Pathol; 1996 Oct; 106(4):487-92. PubMed ID: 8853037
[TBL] [Abstract][Full Text] [Related]
14. High-throughput somatic mutation profiling in pulmonary sarcomatoid carcinomas using the LungCarta™ Panel: exploring therapeutic targets.
Fallet V; Saffroy R; Girard N; Mazieres J; Lantuejoul S; Vieira T; Rouquette I; Thivolet-Bejui F; Ung M; Poulot V; Schlick L; Moro-Sibilot D; Antoine M; Cadranel J; Lemoine A; Wislez M
Ann Oncol; 2015 Aug; 26(8):1748-53. PubMed ID: 25969368
[TBL] [Abstract][Full Text] [Related]
15. Carcinosarcomas (malignant mixed mullerian tumors) of the female genital tract: comparative molecular analysis of epithelial and mesenchymal components.
Kounelis S; Jones MW; Papadaki H; Bakker A; Swalsky P; Finkelstein SD
Hum Pathol; 1998 Jan; 29(1):82-7. PubMed ID: 9445138
[TBL] [Abstract][Full Text] [Related]
16. Expression and alteration of ras and p53 proteins in patients with lung carcinoma accompanied by idiopathic pulmonary fibrosis.
Takahashi T; Munakata M; Ohtsuka Y; Nisihara H; Nasuhara Y; Kamachi-Satoh A; Dosaka-Akita H; Homma Y; Kawakami Y
Cancer; 2002 Aug; 95(3):624-33. PubMed ID: 12209756
[TBL] [Abstract][Full Text] [Related]
17. Mixed pulmonary blastoma and carcinosarcoma.
Olenick SJ; Fan CC; Ryoo JW
Histopathology; 1994 Aug; 25(2):171-4. PubMed ID: 7982680
[TBL] [Abstract][Full Text] [Related]
18. Analysis of K-ras, N-ras, H-ras, and p53 in lung neuroendocrine neoplasms.
Couce ME; Bautista D; Costa J; Carter D
Diagn Mol Pathol; 1999 Jun; 8(2):71-9. PubMed ID: 10475381
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of p53 and K-ras-2 topographic genotyping in endometrial carcinoma: a clinicopathologic and molecular comparison.
Jones MW; Kounelis S; Hsu C; Papadaki H; Bakker A; Swalsky PA; Finkelstein SD
Int J Gynecol Pathol; 1997 Oct; 16(4):354-60. PubMed ID: 9421075
[TBL] [Abstract][Full Text] [Related]
20. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
